What are the primary research applications for BPC-157
This results in: Reduced appetite and caloric intake Enhanced satiety between meals Elevated metabolic tone and mental energy Tesofensine acts centrally to suppress appetite by increasing monoaminergic neurotransmitter levels in the hypothalamus. Astrup, The Lancet What makes Tesofensine unique isnt just its effect on hunger it also elevates dopamine , which may improve mood, motivation, and drive during a cut
Beyond FSP1 there are therapeutic opportunities across the CoQ 10 oxidoreductase network While FSP1 currently has the strongest targetability signal, other CoQ 10 oxidoreductases may be therapeutically leveraged in defined genetic, metabolic or tissue contexts: (1) DHODH axis (mitochondrial defense in select contexts): DHODH connects pyrimidine synthesis to mitochondrial CoQ reduction, and in some settings, DHODH inhibition has been proposed to heighten ferroptosis sensitivity, especially in GPX4-low states
Individually, BPC-157 and KPV each have impressive benefits, but when used together, they create a powerhouse duo that enhances healing and recovery
